Financial Ratios

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE4736.3525.25 (+0.54 %)
PREV CLOSE ( ) 4711.10
OPEN PRICE ( ) 4738.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 239
TODAY'S LOW / HIGH ( )4720.00 4747.10
52 WK LOW / HIGH ( )4595.85 5640
NSE4729.202.8 (+0.06 %)
PREV CLOSE( ) 4726.40
OPEN PRICE ( ) 4750.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 4729.20 (5)
VOLUME 3971
TODAY'S LOW / HIGH( ) 4715.00 4758.15
52 WK LOW / HIGH ( )4575 5642.85
Select year
ParticularsJun2023Jun2022Jun2021Jun2020Dec2018
Operational & Financial Ratios
   Earnings Per Share (Rs)138.23115.98106.51153.0661.29
   CEPS(Rs)155.16132.29124.60170.8074.01
   DPS(Rs)95.0052.50130.00230.00440.00
   Book NAV/Share(Rs)447.62366.99421.59544.82927.78
   Tax Rate(%)26.9724.0224.2128.4035.60
Margin Ratios
   Core EBITDA Margin(%)24.4422.7324.3923.1816.98
   EBIT Margin(%)23.7121.5523.2126.1718.61
   Pre Tax Margin(%)23.6621.5123.1326.1718.61
   PAT Margin (%)17.2816.3517.5318.7411.98
   Cash Profit Margin (%)19.3918.6420.5020.9114.47
Performance Ratios
   ROA(%)11.009.838.6510.824.96
   ROE(%)33.9429.4122.0420.798.95
   ROCE(%)46.0738.4529.0829.0113.90
   Asset Turnover(x)0.640.600.490.580.41
   Sales/Fixed Asset(x)5.275.174.877.044.50
   Working Capital/Sales(x)2.703.132.071.870.63
Efficiency Ratios
   Fixed Capital/Sales(x)0.190.190.210.140.22
   Receivable days27.3622.2028.0621.7340.59
   Inventory Days34.3736.1945.6833.3158.27
   Payable days206.35188.51177.0990.99116.16
Valuation Parameters
   PER(x)37.9736.1052.5226.5750.32
   PCE(x)33.8331.6544.8923.8141.67
   Price/Book(x)11.7311.4113.277.473.32
   Yield(%)1.811.252.325.6514.27
   EV/Net Sales(x)6.735.958.744.514.57
   EV/Core EBITDA(x)24.1223.5933.3815.9122.47
   EV/EBIT(x)26.2726.1137.6717.2324.54
   EV/CE(x)3.713.424.462.891.50
   M Cap / Sales7.096.249.214.986.03
Growth Ratio
   Net Sales Growth(%)10.3410.48-25.6059.7021.61
   Core EBITDA Growth(%)22.156.34-31.27122.7370.76
   EBIT Growth(%)24.118.42-34.03124.6259.70
   PAT Growth(%)19.198.89-30.42149.7366.68
   EPS Growth(%)19.198.89-30.42149.7366.68
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)1.721.621.892.353.45
   Quick Ratio(x)1.531.431.672.103.24
   Interest Cover(x)409.05604.26292.60
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.